Below are the top 10 most profitable Pharmaceutical stocks for the last 12 months. Four Chinese companies (TBV, JGBO, RHGP, CSKI) are on the list.
Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) is the 1st most profitable stock in this segment of the market. Its net profit margin was 67.13% for the last 12 months. Its operating profit margin was 24.84% for the same period. Synta Pharmaceuticals Corp. (NASDAQ:SNTA) is the 2nd most profitable stock in this segment of the market. Its net profit margin was 64.89% for the last 12 months. Its operating profit margin was 65.03% for the same period. BioDelivery Sciences International, Inc. (NASDAQ:BDSI) is the 3rd most profitable stock in this segment of the market. Its net profit margin was 59.44% for the last 12 months. Its operating profit margin was 64.13% for the same period. PDL BioPharma Inc. (NASDAQ:PDLI) is the 4th most profitable stock in this segment of the market. Its net profit margin was 48.42% for the last 12 months. Its operating profit margin was 85.58% for the same period. Myriad Genetics, Inc. (NASDAQ:MYGN) is the 5th most profitable stock in this segment of the market. Its net profit margin was 38.26% for the last 12 months. Its operating profit margin was 37.19% for the same period.
Tiens Biotech Group (USA), Inc. (AMEX:TBV) is the 6th most profitable stock in this segment of the market. Its net profit margin was 35.20% for the last 12 months. Its operating profit margin was 37.89% for the same period. Jiangbo Pharmaceuticals, Inc. (NASDAQ:JGBO) is the 7th most profitable stock in this segment of the market. Its net profit margin was 34.51% for the last 12 months. Its operating profit margin was 51.60% for the same period. Renhuang Pharmaceuticals, Inc. (AMEX:RHGP) is the 8th most profitable stock in this segment of the market. Its net profit margin was 34.46% for the last 12 months. Its operating profit margin was 34.36% for the same period. Valeant Pharmaceuticals International (NYSE:VRX) is the 9th most profitable stock in this segment of the market. Its net profit margin was 29.67% for the last 12 months. Its operating profit margin was 30.02% for the same period. China Sky One Medical, Inc. (NASDAQ:CSKI) is the 10th most profitable stock in this segment of the market. Its net profit margin was 29.67% for the last 12 months. Its operating profit margin was 35.27% for the same period.
(Source:cnanalyst)
No comments:
Post a Comment